TMED vs. GERM

Last updated Jun 25, 2026

TMED (T. Rowe Price Health Care ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds. Over the past year, TMED returned 33.64% vs 0.00% for GERM. TMED charges 0.44%/yr vs 0.68%/yr for GERM.

Performance

TMED vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Health Care ETF (TMED) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

TMED

• 1D: 1.71%
• 1M: 5.92%
• YTD: 10.47%
• 6M: 9.58%
• 1Y: 33.64%
• 3Y*: —
• 5Y*: —
• 10Y*: —

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TMED vs. GERM - Yearly Performance Comparison

	2026 (YTD)	2025
TMED T. Rowe Price Health Care ETF	10.47%	19.49%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%

Return for Risk

TMED vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMED

TMED Risk / Return Rank: 66
TMED Sharpe Ratio Rank: 66
TMED Sortino Ratio Rank: 69
TMED Omega Ratio Rank: 61
TMED Calmar Ratio Rank: 70
TMED Martin Ratio Rank: 64

GERM

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMED vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TMED	GERM	Difference
Sharpe ratio: Return per unit of total volatility	1.86	—	—
Sortino ratio: Return per unit of downside risk	2.72	—	—
Omega ratio: Gain probability vs. loss probability	1.32	—	—
Calmar ratio: Return relative to maximum drawdown	3.04	—	—
Martin ratio: Return relative to average drawdown	9.95	—	—

Drawdowns

TMED vs. GERM - Drawdown Comparison

The maximum TMED drawdown since its inception was -11.11%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for TMED and GERM.

Drawdown Indicators

	TMED	GERM	Difference
Max Drawdown Largest peak-to-trough decline	-11.11%	0.00%	-11.11%
Max Drawdown (1Y) Largest decline over 1 year	-11.11%	0.00%	-11.11%
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	-2.47%	0.00%	-2.47%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.39%	0.00%	+3.39%

Volatility

TMED vs. GERM - Volatility Comparison

T. Rowe Price Health Care ETF (TMED) has a higher volatility of 6.00% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that TMED's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TMED	GERM	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.00%	0.00%	+6.00%
Volatility (6M) Calculated over the trailing 6-month period	13.61%	0.00%	+13.61%
Volatility (1Y) Calculated over the trailing 1-year period	18.21%	0.00%	+18.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.08%	0.00%	+18.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.08%	0.00%	+18.08%

TMED vs. GERM - Expense Ratio Comparison

TMED has a 0.44% expense ratio, which is lower than GERM's 0.68% expense ratio.

Dividends

TMED vs. GERM - Dividend Comparison

TMED's dividend yield for the trailing twelve months is around 0.49%, while GERM has not paid dividends to shareholders.

Position	TTM	2025
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%
TMED T. Rowe Price Health Care ETF	0.49%	0.54%

Frequently Asked Questions

Which is riskier, TMED or GERM?

TMED has higher volatility (6.00%) compared to GERM (0.00%). In terms of maximum drawdown, TMED dropped -11.11% vs GERM's 0.00%.

Which ETF is better, TMED or GERM?

On 1-year performance, TMED leads with 33.64% vs 0.00% for GERM. On fees, TMED is cheaper at 0.44% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, TMED or GERM?

Over the 1-year period, TMED has performed better with a 33.64% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, TMED or GERM?

TMED is cheaper with a 0.44% expense ratio, compared with 0.68% for GERM.

Which ETF pays a higher dividend yield, TMED or GERM?

TMED has the higher dividend yield at 0.49%, compared with 0.00% for GERM.

What is the main difference between TMED and GERM?

They also come from different issuers: T. Rowe Price and Amplify. Their fees differ too: 0.44% for TMED and 0.68% for GERM.